Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Plos One|March 23, 2017
C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizationsYu-Wei Roy Chen, Virginia Chen, Zsuzsanna Hollander, et al.
Hematology (Amsterdam, Netherlands)|September 7, 2020
IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two casesDeonne Thaddeus V Gauiran, Krista M Marcon, Mari L DeMarco, et al.
Annals of the American Thoracic Society|March 31, 2016
Identifying Molecular Mechanisms of the Late-Phase Asthmatic Response by Integrating Cellular, Gene, and Metabolite Levels in BloodAmrit Singh, Casey P Shannon, Young Woong Kim, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 19, 2019
Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samplesNawaf M Alotaibi, Virginia Chen, Zsuzsanna Hollander, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 2, 2018
Phenotyping COPD exacerbations using imaging and blood-based biomarkersNawaf M Alotaibi, Virginia Chen, Zsuzsanna Hollander, et al.
Frontiers in Transplantation|July 12, 2024
Comprehensive immune profiling of SARS-CoV-2 infected kidney transplant patientsFranz Fenninger, Karen R Sherwood, Vivian Wu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 10, 2024
Clinical value of Alzheimer's disease biomarker testingKhushbu J Patel, David Yang, John R Best, et al.
Clinical Biochemistry|May 11, 2020
Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparisonAndre Mattman, Brian M Gilfix, Sharon Xuehui Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 30, 2024
ADNI Biomarker Core: A review of progress since 2004 and future challengesLeslie M Shaw, Magdalena Korecka, Edward B Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 22, 2025
Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkersJoanne Rodda, Lindsey A Kuchenbecker, Wyllians V Borelli, et al.
Pageof 10